Search research articles
Contact Us
Filters
Showing results (191-200 of 324) with videos related to
Page
of 33
Sort By:
International Journal of Clinical Practice
|
June 4, 2010
Counterweight - counter-cost, counter-loss
M E J Lean, J P D Reckless, N Finer, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1983
Factors affecting outcome in hypoxic-ischemic encephalopathy in term infants
N N Finer, C M Robertson, K L Peters, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1984
An evaluation of theophylline for idiopathic apnea of infancy
N N Finer, K L Peters, L M Duffley, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1991
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity
F Jamali, R T Coutts, F Malek, et al.
Critical Care Medicine
|
October 24, 2002
Cost-effectiveness of inhaled nitric oxide in near-term and term infants with respiratory failure: eighteen- to 24-month follow-up for Canadian patients
Philip Jacobs, Neil N Finer, Konrad Fassbender, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 1, 1994
ASO consensus statement on obesity. UK Association for the Study of Obesity
P G Kopelman, N Finer, K R Fox, et al.
Pediatrics
|
April 3, 2002
Role of L-carnitine in apnea of prematurity: a randomized, controlled trial
Jane O'Donnell, Neil N Finer, Wade Rich, et al.
The Journal of Pediatrics
|
July 13, 2000
Postnatal steroids: short-term gain, long-term pain?
N N Finer, A Craft, Y E Vaucher, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 11, 2000
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
N Finer, W P James, P G Kopelman, et al.
Diabetes, Obesity & Metabolism
|
February 28, 2001
Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study
N Finer, S R Bloom, G S Frost, et al.
Page
of 33
Search research articles
Search
Showing results (191-200 of 324) with videos related to
Sort By:
Page
of 33
International Journal of Clinical Practice
|
June 4, 2010
Counterweight - counter-cost, counter-loss
M E J Lean, J P D Reckless, N Finer, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1983
Factors affecting outcome in hypoxic-ischemic encephalopathy in term infants
N N Finer, C M Robertson, K L Peters, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1984
An evaluation of theophylline for idiopathic apnea of infancy
N N Finer, K L Peters, L M Duffley, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1991
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity
F Jamali, R T Coutts, F Malek, et al.
Critical Care Medicine
|
October 24, 2002
Cost-effectiveness of inhaled nitric oxide in near-term and term infants with respiratory failure: eighteen- to 24-month follow-up for Canadian patients
Philip Jacobs, Neil N Finer, Konrad Fassbender, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 1, 1994
ASO consensus statement on obesity. UK Association for the Study of Obesity
P G Kopelman, N Finer, K R Fox, et al.
Pediatrics
|
April 3, 2002
Role of L-carnitine in apnea of prematurity: a randomized, controlled trial
Jane O'Donnell, Neil N Finer, Wade Rich, et al.
The Journal of Pediatrics
|
July 13, 2000
Postnatal steroids: short-term gain, long-term pain?
N N Finer, A Craft, Y E Vaucher, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 11, 2000
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
N Finer, W P James, P G Kopelman, et al.
Diabetes, Obesity & Metabolism
|
February 28, 2001
Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study
N Finer, S R Bloom, G S Frost, et al.
Page
of 33